Cubist Systematic Strategies, LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 80 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 4.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$9,295
-32.1%
10,049
-20.0%
0.00%
Q1 2023$13,698
-58.5%
12,567
-44.5%
0.00%
Q4 2022$33,037
+725.9%
22,628
+980.6%
0.00%
Q2 2022$4,000
-95.6%
2,094
-95.3%
0.00%
-100.0%
Q1 2022$91,000
-69.9%
44,200
-45.1%
0.00%
-66.7%
Q4 2021$302,000
+0.7%
80,521
+38.9%
0.00%
-25.0%
Q3 2021$300,000
+614.3%
57,953
+485.4%
0.00%
Q2 2021$42,000
+90.9%
9,899
+135.7%
0.00%
Q1 2021$22,000
-81.2%
4,200
-80.6%
0.00%
-100.0%
Q4 2020$117,000
-40.9%
21,682
+9.8%
0.00%
-33.3%
Q2 2020$198,000
+125.0%
19,744
+29.6%
0.00%
-25.0%
Q4 2018$88,000
-44.7%
15,233
+29.7%
0.00%
-55.6%
Q3 2018$159,000
-34.0%
11,741
-42.3%
0.01%
-25.0%
Q2 2018$241,000
-5.1%
20,344
-10.0%
0.01%
-20.0%
Q1 2018$254,000
+96.9%
22,615
+16.8%
0.02%
+114.3%
Q4 2017$129,000
-29.1%
19,370
-12.6%
0.01%
-30.0%
Q3 2017$182,000
+2500.0%
22,169
+1747.4%
0.01%
Q1 2017$7,0001,200
+17042.9%
0.00%
Q4 2015$070.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$2,341,0003.33%
Matrix Capital Management Company, LP 38,974,185$66,256,0001.50%
NEA Management Company, LLC 17,082,612$29,040,0001.49%
Endurant Capital Management LP 1,824,065$3,101,0001.09%
Long Focus Capital Management, LLC 4,679,491$7,955,0000.83%
Key Client Fiduciary Advisors, LLC 416,166$707,0000.69%
PFM Health Sciences, LP 9,109,780$15,487,0000.59%
ACT CAPITAL MANAGEMENT, LLC 90,000$153,0000.21%
DAFNA Capital Management LLC 351,064$597,0000.16%
Rock Springs Capital Management LP 2,357,544$4,008,0000.12%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders